Business Model Changes Across Stakeholders Cause Operational Change among SDs in 2017 Over the next three years, the specialty distribution channel will continue to transform, with four notable trends immediately impacting current SD operations and business development: Specialty pharmacies respond to and pursue direct biopharmaceutical company contracts, purposefully eliminating product flow through SDs. Payers and biopharmaceutical companies narrow their networks, consolidating specialty product dispensing volume to fewer SPs and potentially increasing those SPs' buying power with their SDs. Industry consolidation and shifts in site of care transform SDs' customer base and financial outlook. Payers, providers, and biopharmaceutical companies need more services as the healthcare landscape shifts to value-based care, compelling SDs to expand their offerings to product acquisition customers. Request slides info@healthstrategies.com